FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity People and Community FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity admin January 16, 2025 Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions... Read More Read more about FDA Approves Tirzepatideas the First and Only Prescription Medicine for Moderate-to-Severe Obstructive Sleep Apnea in Adults with Obesity
